You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
滬深股市跌幅擴至逾1% 保險及白酒股領跌 醫藥板塊逆市續升
阿思達克 01-21 11:13

武漢的新型冠狀病毒肺炎個案持續擴散,國家衛健委高級專家組組長鍾南山認為,武漢的新型冠狀病毒肺炎肯定有人傳人,建議暫不要去武漢。滬深股市扭轉昨天高收強勢,上證低開0.3%,沽壓持續增大,最低見3,054,現造3,058,回吐1.2%;深成扭轉昨天高收回升1.5%至11,115創約兩年高強勢,今早低開0.3%,跌幅擴大,最低見10,948,現造10,974,回吐1.3%;滬深300低見4,118,現造4,123,回吐1.5%。

板塊方面普遍向下,跌幅過半超過1%-2%,豬肉板塊、白酒、食品飲粁、新零售、稀土永磁、成渝特區及休閒服務跌幅居前;在線旅遊更挫3.2%。相反,智慧城市、醫藥生物、健康中國、湖南槐板、智能電網、病毒防治、中藥及工業大麻升1%-1.6%。

AH股幾乎全面向下,保險股全面跌1.4%-3.1%,國壽(601628.SH)、太保(601601.SH)及新華保險(601336.SH)最傷,分別報33.24元(人民幣下同)、36.72元及49.54元。

中興(000063.SZ)、濰柴(000338.SZ)、一拖(601038.SH)、金風(002202.SZ)、洛鉬(603993.SH)、中聯重科(000157.SZ)及江銅(600362.SH)依跌2.5%-4.2%,前者及後者分別報39.06元及15.69元。

三大汽車股跌1.8%-3.2%,昨天創逾八個月高的比亞迪(002594.SZ)回吐壓力最大,56.89元。

不過,醫藥股逆市續升,尤其是新華製藥(000756.SZ)續漲逾5%曾高見9.37元創逾九個月高;白雲山(600332.SH)也續升2.8%曾見40.48元創半年高。此外,中信建設(601066.SH)也升2.1%曾高見32.95元。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account